Author Archives: Marta Figueiredo PhD

Recorlev Lessens Cushing’s Symptoms, Eases Depression, SONICS Trial Data Show

Recorlev (levoketoconazole), Strongbridge Biopharma’s oral investigational therapy, lessens disease symptoms and depression, and improves quality of life among people with endogenous Cushing’s syndrome, according to data from the Phase 3 SONICS trial. Notably, the therapy was found to particularly ease symptoms among female patients. “People with Cushing’s syndrome…